No Additional Prognostic Value of Genetic Information in the Prediction of Vascular Events after Cerebral Ischemia of Arterial Origin: The PROMISe Study.
Patients who have suffered from cerebral ischemia have a high risk of recurrent vascular events. Predictive models based on classical risk factors typically have limited prognostic value. Given that cerebral ischemia has a heritable component, genetic information might improve performance of these r...
Main Authors: | Sefanja Achterberg, L Jaap Kappelle, Paul I W de Bakker, Matthew Traylor, Ale Algra, SMART Study Group and the METASTROKE Consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4408031?pdf=render |
Similar Items
-
Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease.
by: Philip H C Kremer, et al.
Published: (2015-01-01) -
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
by: Algra Ale, et al.
Published: (2000-11-01) -
Oleanolic acid: a promising neuroprotective agent for cerebral ischemia
by: Caltana Laura, et al.
Published: (2015-01-01) -
Risk of intracerebral hemorrhage in patients with arterial versus cardiac origin of cerebral ischemia on aspirin or placebo: analysis of individual patient data from 9 trials.
by: Ariesen, M, et al.
Published: (2004) -
Melatonin: a promising neuroprotective agent for cerebral ischemia-reperfusion injury
by: Majid Tozihi, et al.
Published: (2023-08-01)